BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

785 related articles for article (PubMed ID: 12237909)

  • 1. Morphology and therapeutic strategies for neuroendocrine tumors of the genitourinary tract.
    Helpap B
    Cancer; 2002 Oct; 95(7):1415-20. PubMed ID: 12237909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroendocrine carcinomas of the prostate and urinary bladder: a diagnostic and therapeutic challenge.
    Helpap B; Klöppel G
    Virchows Arch; 2002 Mar; 440(3):241-8. PubMed ID: 11889593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary, pure, large-cell neuroendocrine carcinoma of the urinary bladder.
    Hailemariam S; Gaspert A; Komminoth P; Tamboli P; Amin M
    Mod Pathol; 1998 Oct; 11(10):1016-20. PubMed ID: 9796733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathologic features of neuroendocrine carcinomas of the stomach: appraisal of small cell and large cell variants.
    Matsui K; Jin XM; Kitagawa M; Miwa A
    Arch Pathol Lab Med; 1998 Nov; 122(11):1010-7. PubMed ID: 9822131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical differentiation of high-grade prostate carcinoma from urothelial carcinoma.
    Chuang AY; DeMarzo AM; Veltri RW; Sharma RB; Bieberich CJ; Epstein JI
    Am J Surg Pathol; 2007 Aug; 31(8):1246-55. PubMed ID: 17667550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retrospective study of clinicopathologic features and prognosis of high-grade neuroendocrine carcinoma of the esophagus.
    Maru DM; Khurana H; Rashid A; Correa AM; Anandasabapathy S; Krishnan S; Komaki R; Ajani JA; Swisher SG; Hofstetter WL
    Am J Surg Pathol; 2008 Sep; 32(9):1404-11. PubMed ID: 18670347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is nonsmall cell type high-grade neuroendocrine carcinoma of the tubular gastrointestinal tract a distinct disease entity?
    Shia J; Tang LH; Weiser MR; Brenner B; Adsay NV; Stelow EB; Saltz LB; Qin J; Landmann R; Leonard GD; Dhall D; Temple L; Guillem JG; Paty PB; Kelsen D; Wong WD; Klimstra DS
    Am J Surg Pathol; 2008 May; 32(5):719-31. PubMed ID: 18360283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of high molecular weight cytokeratins, but not p63, in the differential diagnosis of neuroendocrine and basaloid carcinomas of the head and neck.
    Serrano MF; El-Mofty SK; Gnepp DR; Lewis JS
    Hum Pathol; 2008 Apr; 39(4):591-8. PubMed ID: 18284937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokeratin expression patterns in low-grade papillary urothelial neoplasms of the urinary bladder.
    Ramos D; Navarro S; Villamón R; Gil-Salom M; Llombart-Bosch A
    Cancer; 2003 Apr; 97(8):1876-83. PubMed ID: 12673713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunophenotype of high-grade prostatic adenocarcinoma and urothelial carcinoma.
    Genega EM; Hutchinson B; Reuter VE; Gaudin PB
    Mod Pathol; 2000 Nov; 13(11):1186-91. PubMed ID: 11106075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ovarian nonsmall cell neuroendocrine carcinoma: a clinicopathologic and immunohistochemical study of 11 cases.
    Veras E; Deavers MT; Silva EG; Malpica A
    Am J Surg Pathol; 2007 May; 31(5):774-82. PubMed ID: 17460463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastric neuroendocrine carcinoma: clinicopathologic review and immunohistochemical study of E-cadherin and Ki-67 as prognostic markers.
    Boo YJ; Park SS; Kim JH; Mok YJ; Kim SJ; Kim CS
    J Surg Oncol; 2007 Feb; 95(2):110-7. PubMed ID: 17066436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Large cell and small cell neuroendocrine bladder carcinoma: immunohistochemical and outcome study in a single institution.
    Alijo Serrano F; Sánchez-Mora N; Angel Arranz J; Hernández C; Alvarez-Fernández E
    Am J Clin Pathol; 2007 Nov; 128(5):733-9. PubMed ID: 17951193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcitonin-producing well-differentiated neuroendocrine carcinoma (carcinoid tumor) of the urinary bladder: case report.
    Mascolo M; Altieri V; Mignogna C; Napodano G; De Rosa G; Insabato L
    BMC Cancer; 2005 Jul; 5():88. PubMed ID: 16048646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical profile of high-grade urothelial bladder carcinoma and prostate adenocarcinoma.
    Mhawech P; Uchida T; Pelte MF
    Hum Pathol; 2002 Nov; 33(11):1136-40. PubMed ID: 12454820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genitourinary small cell carcinoma: determination of clinical and therapeutic factors associated with survival.
    Mackey JR; Au HJ; Hugh J; Venner P
    J Urol; 1998 May; 159(5):1624-9. PubMed ID: 9554367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rhabdomyosarcoma of the urinary bladder in adults: predilection for alveolar morphology with anaplasia and significant morphologic overlap with small cell carcinoma.
    Paner GP; McKenney JK; Epstein JI; Amin MB
    Am J Surg Pathol; 2008 Jul; 32(7):1022-8. PubMed ID: 18469707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study of moderately differentiated neuroendocrine carcinomas of the larynx and an examination of non-neoplastic larynx tissue for neuroendocrine cells.
    Chung JH; Lee SS; Shim YS; Kim SY; Nam SY; Kim DH; Cho KJ
    Laryngoscope; 2004 Jul; 114(7):1264-70. PubMed ID: 15235358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small cell carcinoma of the prostate. A morphologic and immunohistochemical study of 95 cases.
    Wang W; Epstein JI
    Am J Surg Pathol; 2008 Jan; 32(1):65-71. PubMed ID: 18162772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Non-urothelial tumors of the urinary tract].
    Mikuz G
    Verh Dtsch Ges Pathol; 1993; 77():180-98. PubMed ID: 7511278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.